Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses VOR in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named VOR in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jean-Paul Kress | $344,615 | $400,000 | $0 | $64,013,465 | $251,425 | $0 | $18,064 | $65,027,569 |
| President, Chief Executive Officer and Chairman | ||||||||
| Sandesh Mahatme | 217,846 | 274,000 | 35,262,185 | 3,540,099 | 102,996 | 0 | 8,972 | 39,406,098 |
| Chief Financial Officer | ||||||||
| Qing Zuraw | 243,385 | 100,000 | 2,230,250 | 8,570,852 | 0 | 0 | 692,706 | 11,837,193 |
| Former Chief Development Officer | ||||||||
| Robert Ang | 515,026 | 0 | 184,250 | 1,176,895 | 0 | 0 | 1,488,224 | 3,364,395 |
| Former President and Chief Executive Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Jean-Paul Kress | $65,027,569 | — | — | — |
| Sandesh Mahatme | 39,406,098 | — | — | — |
| Qing Zuraw | 11,837,193 | — | — | — |
| Robert Ang | 3,364,395 | 2,220,349 | — | +1,144,046 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Robert Ang | Option | 106,332 | 86.02 | — |
| Qing Zuraw | RSU | 46,854 | — | 612,850 |
| Jean-Paul Kress | Option | 4,164,831 | 17.8 | — |
| Robert Ang | Option | 7,364 | 43.52 | — |
| Robert Ang | Option | 7,002 | 38.08 | — |
| Robert Ang | Option | 12,874 | 111 | — |
| Robert Ang | Option | 2,552 | 360 | — |
| Robert Ang | Option | 18,799 | 172.6 | — |
| Qing Zuraw | Option | 218,652 | 47.6 | — |
| Robert Ang | Option | 8,625 | 99.4 | — |
| Robert Ang | Option | 22,661 | 48.2 | — |
| Robert Ang | Option | 41,249 | 26.8 | — |
| Sandesh Mahatme | Option | 1,388,274 | 17.8 | — |
A core objective of our compensation program is to enable the attraction, retention, and motivation of top talent that will provide us with the expertise and skills necessary to deliver on our short- and long-term goals. We consider compensation for comparable positions at peer companies, historical compensation levels, individual performance, and our desire to motivate employees to achieve short- and long-term results in the best interests of our stockholders.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Erez KalirIndependent · Audit | $42,033 | — | $81,000 | — | — | $123,033 |
| Alexander (Bo) CumboIndependent · Compensation (Chair) · Nominating and Corporate Governance | 22,973 | — | 98,392 | — | — | 121,365 |
| Michel DetheuxIndependent · Audit | 20,958 | — | 98,392 | — | — | 119,350 |
| Sarah ReedIndependent · Departed during FY | 13,283 | — | 91,925 | — | — | 105,208 |
| Daniella BeckmanIndependent · Lead Independent Director · Audit (Chair) · Compensation | 60,000 | — | 4,200 | — | — | 64,200 |
| Matthew PattersonIndependent · Departed during FY | 53,374 | — | 4,200 | — | — | 57,574 |
| Fouad NamouniIndependent · Compensation · Nominating and Corporate Governance (Chair) | 46,889 | — | 4,200 | — | — | 51,089 |
| Joshua ResnickIndependent · Departed during FY | 34,565 | — | 4,200 | — | — | 38,765 |
| David LubnerIndependent · Departed during FY | 31,107 | — | 4,200 | — | — | 35,307 |
| Andrew LevinIndependent | 1,522 | — | 30,359 | — | — | 31,881 |
| Wouter JoustraIndependent | 1,522 | — | 30,359 | — | — | 31,881 |
| Sven (Bill) Ante LundbergIndependent · Departed during FY | 27,310 | — | 4,200 | — | — | 31,510 |
| Jean-Paul KressEmployee director · Board Chair | — | — | — | — | — | 0 |
| Robert AngEmployee director · Departed during FY | — | — | — | — | — | 0 |
| Annual cash retainer | $40,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 10,000 / 8,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $355,536 |
| Equity awards (grant-date value) | $0 |
| All other compensation | $0 |
| Total cost of the board | $355,536 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Vor Biopharma | 2025 | Jean-Paul Kress | $344,615 | $0 | $64,013,465 | $251,425 | $65,027,569 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Jean-Paul Kress | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Executive Compensation”. As printed: 65,027,569. Filing ↗machine: r2 · c28 · span 644794–644804 |
| 2 | Section 01, Sandesh Mahatme | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Executive Compensation”. As printed: 39,406,098. Filing ↗machine: span 685941–685951 |
| 3 | Section 01, Qing Zuraw | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Executive Compensation”. As printed: 11,837,193. Filing ↗machine: r8 · c28 · span 705218–705228 |
| 4 | Section 01, Robert Ang | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Executive Compensation”. As printed: 3,364,395. Filing ↗machine: r4 · c28 · span 664135–664144 |
| 5 | Section 08, Erez Kalir | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 123,033. Filing ↗machine: span 1016298–1016507 |
| 6 | Section 08, Alexander (Bo) Cumbo | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 121,365. Filing ↗machine: span 1002196–1002405 |
| 7 | Section 08, Michel Detheux | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 119,350. Filing ↗machine: span 1006792–1007001 |
| 8 | Section 08, Sarah Reed | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 105,208. Filing ↗machine: span 1040076–1040285 |
| 9 | Section 08, Daniella Beckman | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 64,200. Filing ↗machine: span 997595–997803 |
| 10 | Section 08, Matthew Patterson | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 57,574. Filing ↗machine: span 1035325–1035533 |
| 11 | Section 08, Fouad Namouni | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 51,089. Filing ↗machine: span 1049425–1049633 |
| 12 | Section 08, Joshua Resnick | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 38,765. Filing ↗machine: span 1044832–1045040 |
| 13 | Section 08, David Lubner | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 35,307. Filing ↗machine: span 1025803–1026011 |
| 14 | Section 08, Andrew Levin | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 31,881. Filing ↗machine: span 1021051–1021259 |
| 15 | Section 08, Wouter Joustra | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 31,881. Filing ↗machine: span 1011547–1011755 |
| 16 | Section 08, Sven (Bill) Ante Lundberg | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 31,510. Filing ↗machine: span 1030568–1030776 |
| 17 | Section 08, Jean-Paul Kress | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 18 | Section 08, Robert Ang | DEF 14A | 2026-04-27 | 0001193125-26-181883 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 19 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 20 | Section 09b board cost (computed) | Computed | — | computed | Cash 355,536 + equity 0 + all other 0 = 355,536, summed across the director compensation table rows.machine: formula: Σ = 355,536 |
| 21 | Vor Biopharma (subject), Section 10b CEO total | DEF 14A | 2026-04-27 | 0001193125-26-181883 | CEO total compensation as printed in Vor Biopharma's own proxy. As printed: 65,027,569. Filing ↗machine: r2 · c28 · span 644794–644804 |